دورية أكاديمية
LBP-18 - ALG-000184, a capsid assembly modulator, dosed with entecavir for up to 28 weeks is well tolerated and resulted in substantial declines in surface antigen levels in untreated Hepatitis B e antigen positive subjects with chronic hepatitis B
العنوان: | LBP-18 - ALG-000184, a capsid assembly modulator, dosed with entecavir for up to 28 weeks is well tolerated and resulted in substantial declines in surface antigen levels in untreated Hepatitis B e antigen positive subjects with chronic hepatitis B |
---|---|
المؤلفون: | Hou, Jinlin, Ding, Yanhua, Niu, Junqi, Liang, Xieer, Yuen, Man-Fung, Gane, Edward J., Agarwal, Kosh, Wu, Min, Le, Kha, Venkatraman, Meenakshi, Westland, Christopher, Maderazo, Maida, Chanda, Sushmita, Beigelman, Leonid, Blatt, Lawrence, Lin, Tse-I, McClure, Matt, Fry, John |
المصدر: | In Journal of Hepatology June 2023 78 Supplement 1:S112-S113 |
قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!